CATrends: Deceptive Deals
The holiday shopping season is here. Tread carefully.
Actos
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
The Latest
Skull Shaver’s Early Bird Sale
Trying to take advantage of this sale may not be as smooth as advertised.
Roblox Bid for Ad Riches Collides With Wary Sponsors, Developers
Cecilia D’Anastasio, Bloomberg
UIC Aspire Grant
TINA.org digs into school’s debt-free claims.
TINA.org Joins Consumer Advocates to Keep FTC Bipartisan
Why agency independence is in the best interests of consumers.